The global Neurogenetic Testing Market is likely to witness expedited growth In Upcoming Years. Its virtual world taking the centre-stage as of now. With end-users asking for specialized settings and solutions, the other side of the table would be fortified with reduced cost on the part of maintenance. It is expected that close to 50% of the enterprise is eying virtual mode of operation by the year 2040.
These may include dementia, hereditary neuropathy, Parkinson disease, Epileptic disorders, etc. The Neurogenetic Testing market is majorly driven by advancements in DNA sequencing techniques and increasing research in the life science domain. These method provide an accurate course of treatment of the disorder.
Get Sample Copy of this Report@ https://www.persistencemarketresearch.com/samples/32899
Another driver is the prevalence of various neurological disorders. According to a WHO report, the European region contribute 11.2% of global burden of neurological disorder followed by Western Pacific region with 10%. According to a report, the number of deaths caused by neurological disorder is increased by 39% in the past 30 years.
This increase in the prevalence therefore acts as a driven for neurological testing market. An increase in the awareness about treatments and R & D investment by the companies for developing new techniques and acquiring other companies is expected to increase demand for neurogenetic testing during the forecast period.
During this pandemic times, the hospitals started giving neurogenetics counselling through telephone videoconferencing (telegenetics) for remote places. However, this pandemic has allowed researchers to come up with new techniques for neurogenetic testing. The market had an overall negative impact due to COVID-19.
Get A Customized Scope To Match Your Need Ask An Expert – sales@persistencemarketresearch.com
- Neurogene Inc.
- Pacific Biosciences of California Inc.
- Victorian Clinical Genetics Services
- MedGenome
- Blueprint Genetics Oy
- Laboratory Corporation of America.
Followed by North America, the region that is expected to dominate the market is Asia. This is because of increase in prevalence of neurological disorders in this region. According to a report, the prevalence of neurological disorders are higher in low and middle income countries. Apart from this, the advancements in the DNA sequencing technique and an increase in life science research are driving the market.
Request for Table of Content@ https://www.persistencemarketresearch.com/toc/32899
Key Segments
By Technique
- MRI
- Next generation sequencing
- Multiplex ligation-dependent probe amplification (MLPA)
- Fragment analysis PCR
By End-user
- Hospitals
- Specialty clinics
- Research institutes
- Diagnostics laboratories
By Region
- North America
- Latin America
- Europe
- South Asia
- East Asia
- Oceania
- Middle East and Africa
Access Full Report@ https://www.persistencemarketresearch.com/checkout/32899
About Us: Persistence Market Research
Contact Us:
Persistence Market Research
Address – 305 Broadway, 7th Floor, New York City,
NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com
Website – https://www.persistencemarketresearch.com